The Europe Oligonucleotide Synthesis market is expected to reach US$ $ 1,270.95 Mn in 2027 from US$ 518.02 Mn in 2018. The market is estimated to grow with a CAGR of 13.7% from 2019-2027.
The growth of the market is driven by the factors such as, research and academic universities are collaborating with commercial market players to develop techniques and simplify the method of artificial DNA synthesis as well as rise in the number of market players and their focus in the oligonucleotide synthesis are likely to boost the growth of the oligonucleotide synthesis in the region during the forecast period.
Synthetic DNA is widely used in biology. Oligonucleotides are used in many biological and forensic applications as sequence-specific binding agents can help in identifying presence of a specific target DNA sequence. Synthetic oligonucleotides are short stretches of single stranded DNA fragments assembled by chemical synthesis. Due to the simultaneous developments of methods for the rapid and efficient synthesis of oligonucleotides and the advent of molecular biology techniques.
Oligonucleotides have many applications in research, diseases diagnosis, therapeutics, forensic, drug discovery, agriculture and many more. Synthetic oligonucleotides are widely used in the diagnosis of human genetic diseases. In addition, the players operating in the UK oligonucleotide synthesis market have been obtaining funds in order to enhance their product offering. For instance, in March, 2019, UK based privately held biotech company, Procarta Biosystems received a fund of US$ 1.69 Mn (€1.5 m) from the Novo Holdings REPAIR Impact Fund in order to enable the development of novel therapies to combat antimicrobial resistance (AMR).
Researchers are also using oligonucleotides to produce more efficient, greener chemical synthesis. By assembling oligonucleotides together into longer fragments that encode synthetic genes, bacteria or yeast cells can be instructed to produce specific enzymes (a type of protein).
Oligonucleotides also has wide potential for treating various medical conditions. They enable the development of therapeutics as the malfunctioning genes can be targeted, manipulated, silenced and/or modulated. For instance, Ionis Pharmaceuticals has dedicated its existence to oligonucleotide therapeutic development, particularly antisense oligonucleotide (ASO) therapeutics. Thus, the promising potential of synthesized oligonucleotides in various fields drives the market growth.
Spain is expected to lead the market in the Europe region owing to growing number of partnerships and collaborations among private players, rising investments and funding dedicated to the biotechnology companies as well as academic and research institutes for gene synthesis based end products. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Europe region during the forecast period.
Exhibit: Italy Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
EUROPE OLIGONUCLEOTIDE SYNTHESIS – MARKET SEGMENTATION
By Product
By Application
By End User
By Geography
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 518.02 Million |
| Market Size by 2027 | US$ $ 1,270.95 Million |
| CAGR (2019 - 2027) | 13.7% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Oligonucleotide Synthesis Market is valued at US$ 518.02 Million in 2018, it is projected to reach US$ $ 1,270.95 Million by 2027.
As per our report Europe Oligonucleotide Synthesis Market, the market size is valued at US$ 518.02 Million in 2018, projecting it to reach US$ $ 1,270.95 Million by 2027. This translates to a CAGR of approximately 13.7% during the forecast period.
The Europe Oligonucleotide Synthesis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Oligonucleotide Synthesis Market report:
The Europe Oligonucleotide Synthesis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Oligonucleotide Synthesis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Oligonucleotide Synthesis Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Oligonucleotide Synthesis Market
